• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吲哚美辛从羟丙甲纤维素/果胶/钙基质片剂中的双相释放:I. 表征与机理研究。

Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: I. Characterization and mechanistic study.

作者信息

Wu Baojian, Chen Zhukang, Wei Xiuli, Sun Ningyun, Lu Yi, Wu Wei

机构信息

Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, PR China.

出版信息

Eur J Pharm Biopharm. 2007 Nov;67(3):707-14. doi: 10.1016/j.ejpb.2007.04.016. Epub 2007 Apr 30.

DOI:10.1016/j.ejpb.2007.04.016
PMID:17540549
Abstract

Calcium-induced crosslinking of pectin acts as the dominating factor controlling drug release from pectin-based matrices. The same interaction was employed to modify indomethacin release from HPMC/pectin/calcium matrix in this study. The aim was to characterize the release profiles, and to study the formulation variables and the underlying mechanisms. The matrix tablet was made up of pectin HM 70, calcium chloride and HPMC K4M, and prepared by the wet granulation method. In vitro release was performed in water and characterized by the power law. Matrix erosion was evaluated by studying the weight loss and pectin release. Biphasic release of indomethacin from the HPMC/pectin/calcium matrix tablet was observed, and extraordinary power law exponent n values of over 1.0 were observed. Increase in calcium amount led to more significant retardation on drug release. The two power law parameters, n and K, correlated to the amount of calcium in the matrix. A lag time of over 4 h can be achieved at HPMC/pectin/calcium chloride amount of 100 mg/100 mg/100 mg. Both matrix weight loss and pectin release were linearly correlated to indomethacin release, indicating erosion-controlled drug release mechanisms. The hybrid matrix showed retarded erosion and hydration rate, which served as the basis for retarded indomethacin release. It is concluded that the pectin/calcium interaction can be employed to modify drug release from HPMC/pectin/calcium matrix tablet with biphasic release patterns for potential timed or site-specific drug delivery.

摘要

钙诱导的果胶交联是控制药物从果胶基基质中释放的主要因素。本研究采用相同的相互作用来改变吲哚美辛从羟丙甲纤维素/果胶/钙基质中的释放。目的是表征释放曲线,研究配方变量和潜在机制。基质片剂由果胶HM 70、氯化钙和羟丙甲纤维素K4M组成,采用湿法制粒法制备。在水中进行体外释放,并以幂律进行表征。通过研究失重和果胶释放来评估基质侵蚀。观察到吲哚美辛从羟丙甲纤维素/果胶/钙基质片剂中的双相释放,并且观察到异常的幂律指数n值超过1.0。钙含量的增加导致药物释放的延迟更显著。两个幂律参数n和K与基质中钙的含量相关。在羟丙甲纤维素/果胶/氯化钙含量为100 mg/100 mg/100 mg时可实现超过4小时的滞后时间。基质失重和果胶释放均与吲哚美辛释放呈线性相关,表明药物释放机制受侵蚀控制。混合基质显示出延迟的侵蚀和水合速率,这是吲哚美辛释放延迟的基础。结论是,果胶/钙相互作用可用于改变羟丙甲纤维素/果胶/钙基质片剂的药物释放,具有双相释放模式,用于潜在的定时或定点给药。

相似文献

1
Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: I. Characterization and mechanistic study.吲哚美辛从羟丙甲纤维素/果胶/钙基质片剂中的双相释放:I. 表征与机理研究。
Eur J Pharm Biopharm. 2007 Nov;67(3):707-14. doi: 10.1016/j.ejpb.2007.04.016. Epub 2007 Apr 30.
2
Biphasic release of indomethacin from HPMC/pectin/calcium matrix tablet: II. Influencing variables, stability and pharmacokinetics in dogs.吲哚美辛从羟丙甲纤维素/果胶/钙基质片剂中的双相释放:II. 影响因素、稳定性及犬体内药代动力学
Eur J Pharm Biopharm. 2008 May;69(1):294-302. doi: 10.1016/j.ejpb.2007.10.001. Epub 2007 Oct 5.
3
Sigmoidal release of indomethacin from pectin matrix tablets: effect of in situ crosslinking by calcium cations.吲哚美辛从果胶基质片剂中的S形释放:钙阳离子原位交联的影响。
Int J Pharm. 2006 Aug 2;318(1-2):132-8. doi: 10.1016/j.ijpharm.2006.03.024. Epub 2006 Mar 29.
4
An in situ crosslinked compression coat comprised of pectin and calcium chloride for colon-specific delivery of indomethacin.一种由果胶和氯化钙组成的原位交联压缩包衣,用于吲哚美辛的结肠特异性递送。
Drug Deliv. 2015 May;22(3):298-305. doi: 10.3109/10717544.2013.879965. Epub 2014 Jan 29.
5
Studies on pectins as potential hydrogel matrices for controlled-release drug delivery.关于果胶作为控释药物递送潜在水凝胶基质的研究。
Drug Dev Ind Pharm. 1999 Dec;25(12):1271-6. doi: 10.1081/ddc-100102298.
6
Colonic delivery of compression coated nisin tablets using pectin/HPMC polymer mixture.使用果胶/羟丙基甲基纤维素聚合物混合物对压缩包衣乳链菌肽片进行结肠给药。
Eur J Pharm Biopharm. 2007 Aug;67(1):202-10. doi: 10.1016/j.ejpb.2007.01.016. Epub 2007 Jan 31.
7
Effect of degree of esterification of pectin and calcium amount on drug release from pectin-based matrix tablets.果胶酯化度和钙含量对果胶基骨架片药物释放的影响。
AAPS PharmSciTech. 2004 Feb 12;5(1):E9. doi: 10.1208/pt050109.
8
Preparation and evaluation of pectin-based colon-specific pulsatile capsule in vitro and in vivo.基于果胶的结肠定位脉冲胶囊的制备及体内外评价。
Arch Pharm Res. 2012 Nov;35(11):1927-34. doi: 10.1007/s12272-012-1109-4. Epub 2012 Dec 4.
9
Naproxen release from sustained release matrix system and effect of cellulose derivatives.萘普生从缓释基质系统中的释放及纤维素衍生物的作用。
Pak J Pharm Sci. 2006 Jul;19(3):251-5.
10
Evaluation of khaya gum as a directly compressible matrix system for controlled release.对卡亚胶作为控释直接压片基质系统的评价。
J Pharm Pharmacol. 2004 Nov;56(11):1365-70. doi: 10.1211/0022357044652.

引用本文的文献

1
Pharmaceutical and pharmacokinetic evaluation of a newly formulated multiparticulate matrix of levodopa and carbidopa.左旋多巴和卡比多巴新剂型多颗粒基质的药学及药代动力学评价
ADMET DMPK. 2022 Oct 15;11(1):97-115. doi: 10.5599/admet.1474. eCollection 2023.
2
A Pharmacokinetic Evaluation of a Pectin-Based Oral Multiparticulate Matrix Carrier of Carbamazepine.卡马西平的果胶基口服多颗粒基质载体的药代动力学评价
Adv Pharmacol Pharm Sci. 2021 Jul 3;2021:5527452. doi: 10.1155/2021/5527452. eCollection 2021.
3
Potential of Cocoa Pod Husk Pectin-Based Modified Release Capsules as a Carrier for Chronodelivery of Hydrocortisone in Sprague-Dawley Rats.
可可豆荚壳果胶基缓释胶囊作为氢化可的松在Sprague-Dawley大鼠体内定时释放载体的潜力。
J Drug Deliv. 2018 Oct 8;2018:9825363. doi: 10.1155/2018/9825363. eCollection 2018.
4
In Vitro Evaluation of Cocoa Pod Husk Pectin as a Carrier for Chronodelivery of Hydrocortisone Intended for Adrenal Insufficiency.可可豆荚壳果胶作为用于肾上腺皮质功能不全的氢化可的松定时释放载体的体外评价
J Drug Deliv. 2017;2017:8284025. doi: 10.1155/2017/8284025. Epub 2017 Dec 24.
5
A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets.氟比洛芬结肠脉冲释放的新方法:双压包衣微型片的制剂与药代动力学
AAPS PharmSciTech. 2015 Dec;16(6):1465-73. doi: 10.1208/s12249-015-0340-y. Epub 2015 May 28.
6
Design and evaluation of matrix base with sigmoidal release profile for colon-specific delivery using a combination of Eudragit and non-ionic cellulose ether polymers.采用 Eudragit 和非离子纤维素醚聚合物组合的结肠定位释放的基质设计与评价。
Drug Deliv Transl Res. 2011 Apr;1(2):132-46. doi: 10.1007/s13346-011-0016-4.
7
Pharmacokinetics of ketorolac tromethamine compression-coated tablets for colon delivery.酮咯酸氨丁三醇压缩包衣片剂的结肠递药药代动力学。
Drug Deliv Transl Res. 2014 Aug;4(4):310-9. doi: 10.1007/s13346-014-0195-x.
8
External Cross-linked Mucoadhesive Microbeads for Prolonged Drug Release: Development and In vitro Characterization.用于延长药物释放的外部交联粘膜粘附微珠:研制与体外特性研究
Indian J Pharm Sci. 2014 Sep;76(5):437-44.
9
Pharmacokinetics of colon-specific pH and time-dependent flurbiprofen tablets.结肠特异性pH和时间依赖性氟比洛芬片的药代动力学
Eur J Drug Metab Pharmacokinet. 2015 Sep;40(3):301-11. doi: 10.1007/s13318-014-0210-0. Epub 2014 Jun 11.
10
Colon targeted guar gum compression coated tablets of flurbiprofen: formulation, development, and pharmacokinetics.结肠靶向瓜尔胶压制包衣氟比洛芬片:制剂、开发和药代动力学。
Biomed Res Int. 2013;2013:287919. doi: 10.1155/2013/287919. Epub 2013 Oct 24.